Experimental mice got injections of the peptide 5 times a week, and the results showed that it suppressed the formation of neoplasms, decreased lungs metastases by 1,6 times, multiple tumors by 2 times, 3,7-fold increase of mice without breast tumors and decrease of mice with 6 or more tumors by 3 times
TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
Mental health monitoring is particularly important
Short-term psychodynamic interventions can support communication, boundary-setting, and the consolidation of emerging relational roles
To ensure the best results, every IV session is tailored to your unique needs
Long-term safety studies, however, have not been conducted (see Concerns and Cautions)